75 related articles for article (PubMed ID: 25518522)
1. [Study of some pharmacological properties of a new adenine derivative].
Iasnetsov ; Ozerov AA; Motin VG; Iasnetsov VV; Karsanova SK; Ivanov IuV; Chel'naia NA
Eksp Klin Farmakol; 2014; 77(10):15-8. PubMed ID: 25518522
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiological study of the mechanism of mexidol action].
Motin VG; Iasnetsov VV; Zabozlaev AA; Karsanova SK; Iasnetsov VV
Eksp Klin Farmakol; 2012; 75(1):3-7. PubMed ID: 22442954
[TBL] [Abstract][Full Text] [Related]
3. Comparing long-term depression with pharmacologically induced synaptic attenuations in young rat hippocampi.
Xiao MY; Niu YP; Wigstrom H
Synapse; 1997 Aug; 26(4):329-40. PubMed ID: 9215592
[TBL] [Abstract][Full Text] [Related]
4. Role of AMPA and NMDA receptors and back-propagating action potentials in spike timing-dependent plasticity.
Fuenzalida M; Fernández de Sevilla D; Couve A; Buño W
J Neurophysiol; 2010 Jan; 103(1):47-54. PubMed ID: 19864442
[TBL] [Abstract][Full Text] [Related]
5. Region-specific role for GluN2B-containing NMDA receptors in injury to Purkinje cells and CA1 neurons following global cerebral ischemia.
Quillinan N; Grewal H; Deng G; Shimizu K; Yonchek JC; Strnad F; Traystman RJ; Herson PS
Neuroscience; 2015 Jan; 284():555-565. PubMed ID: 25450957
[TBL] [Abstract][Full Text] [Related]
6. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats.
Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K
Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519
[TBL] [Abstract][Full Text] [Related]
7. Effects of metabotropic glutamate mGlu5 receptor antagonist on tyrosine phosphorylation of NMDA receptor subunits and cell death in the hippocampus after brain ischemia in rats.
Takagi N; Besshoh S; Marunouchi T; Takeo S; Tanonaka K
Neurosci Lett; 2012 Nov; 530(1):91-6. PubMed ID: 23022504
[TBL] [Abstract][Full Text] [Related]
8. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M
Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
Radenovic L; Selakovic V
Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia.
Pringle AK; Iannotti F; Wilde GJ; Chad JE; Seeley PJ; Sundstrom LE
Brain Res; 1997 Apr; 755(1):36-46. PubMed ID: 9163539
[TBL] [Abstract][Full Text] [Related]
11. Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.
Iwasaki K; Chung EH; Egashira N; Hatip-Al-Khatib I; Mishima K; Egawa T; Irie K; Fujiwara M
Brain Res; 2004 Jan; 995(1):131-9. PubMed ID: 14644478
[TBL] [Abstract][Full Text] [Related]
12. Effects of MK-801 and CNQX on various neurotoxic responses induced by kainic acid in mice.
Lee JK; Choi SS; Lee HK; Han KJ; Han EJ; Suh HW
Mol Cells; 2002 Dec; 14(3):339-47. PubMed ID: 12521295
[TBL] [Abstract][Full Text] [Related]
13. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
Campos F; Alfonso M; Vidal L; Faro LR; Durán R
Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia.
Virgili M; Contestabile A; Barnabei O
Hippocampus; 1995; 5(1):91-7. PubMed ID: 7787950
[TBL] [Abstract][Full Text] [Related]
15. Response properties of antral mechanosensitive afferent fibers and effects of ionotropic glutamate receptor antagonists.
Sengupta JN; Petersen J; Peles S; Shaker R
Neuroscience; 2004; 125(3):711-23. PubMed ID: 15099685
[TBL] [Abstract][Full Text] [Related]
16. Electrical responses in hippocampal slices after prolonged global ischemia: effects of neuroprotectors.
Artemenko DP; Gerasimov VD; Krishtal OA
Brain Res; 2000 Apr; 863(1-2):66-70. PubMed ID: 10773194
[TBL] [Abstract][Full Text] [Related]
17. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
18. [PECULIARITIES OF THE CEREBROVASCULAR EFFECTS OF GLUTAMIC ACID].
Gan'shina TS; Kurza EV; Kurdyumov IN; Maslennikov DV; Mirzoyan RS
Eksp Klin Farmakol; 2016; 79(3):9-12. PubMed ID: 27455572
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
Arias RL; Tasse JR; Bowlby MR
Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
